 |
Meeting Regulatory and Technical Requirements for Organic Impurity Analysis |
Tuesday, September 24, 2013 at 11:00 AM EDT for the US and Tuesday, October 1, 2013 at 15:00 PM CET for Europe
|
Organic impurities cover a wide spectrum of compounds that have varying structures, behaviors, and characteristics. Organic impurities can result from manufacturing, storage conditions, or degradation resulting from light, heat, and other external factors. Deciding what technology or analytical methods to use to detect and measure organic impurities is a challenge. This 60-minute webcast will provide insight on regulatory, compendial, and ICH requirements on organic impurity control and analysis. Learn from leading experts on best practices in analytical method development, method selection, and method validation for detecting and quantifying organic impurities in drug substances and drug products.
Key Learning Objectives
• Learn from experts on the latest regulatory and compendial requirements for organic impurity control and analysis in drug substances and drug products
• Gain insight on selecting the appropriate analytical methods for detection, analysis, and quantification of organic impurities
• Learn from case studies on how best to ensure product quality
|
Moderator:
Patricia Van Arnum
Executive Editor
Pharmaceutical Technology
Speakers:
Tim Watson, PhD
Research Fellow
GCMC Advisory Office
Pfizer
Mark Argentine, PhD
Senior Research Advisor
Analytical Sciences R&D
Eli Lilly
Hildegard Brümmer, PhD
Operational Laboratory Manager
SGS Life Science Services, Berlin
|
IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf, sbarschdorf@advanstar.com.
Register for this FREE Webcast!
|
 |
|